Results for “”

Entry Author Date Location
Would Uber’s IPO Be a Revival or a Reckoning? 08/17/18 Boston
Bio Roundup: Big Approvals, ICER Influence, Drug-Price Pushback & More 08/17/18 National
Best Buy Acquires GTCR’s GreatCall for $800M, Eyeing Aging Boomers 08/15/18 San Diego
SF’s Full Harvest Bags $8.5M to Help Sell “Ugly and Surplus” Produce 08/15/18 San Francisco
Ford’s Autonomic Pairs With Alibaba Cloud On Mobility Hub for China 08/14/18 San Francisco
Alnylam Gets Landmark FDA OK For First-Ever RNAi Drug 08/10/18 Boston
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More 08/10/18 National
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future? 08/08/18 San Francisco
Blockchain Tomatoes & Edible Peels: Startups Innovate to Fight Spoilage 08/06/18 National
The Technology Behind Fighting California’s Fires & Other Disasters 08/06/18 San Francisco
Bio Roundup: Alnylam’s Moment, Read on Rebates, Skinny Plans & More 08/03/18 National
Patients Have “Fingers Crossed” As Alnylam Awaits Historic FDA Decision 08/03/18 Boston
Pernix-Backed Biz Picks Up Orexigen’s Weight Loss Drug for $74M 07/30/18 San Diego
Bio Roundup: An Alzheimer’s Head-Scratcher, OUTBio, GSK & Gilead Shakeups   07/27/18 National
Qualcomm’s Ends Two-Year, $44B Bid for NXP After No Word from China 07/26/18 San Diego
OUTBio, a Biopharma LGBTQ Group, Grows Fast & Ponders Its Future 07/26/18 Boston
Nabriva Bolsters Antibiotics Pipeline with Zavante Acquisition 07/24/18 San Diego
Announcing XCON 2018: A Conference on Technology and Transformation 07/24/18 Boston
Bio Roundup: Drug Prices, CRISPR Caveats, Rubius IPO Pop & More 07/20/18 National
E.U. Slaps $5B Antitrust Fine on Google; Trump Blasts Back With Tweet 07/18/18 San Francisco
New Ethics Code Urges Tech Firms and Coders To Avoid Harming Society 07/17/18 San Francisco
Bio Roundup: Pfizer’s Prices, Novartis Cuts, Gene Therapy Guide & More 07/13/18 National
Broadcom Eyes CA Technologies for $19B After Trump Axed Qualcomm Bid 07/12/18 San Francisco
EU Regulators Approve Akcea’s Inotersen. FDA Decisions Are Next. 07/11/18 Boston
Venture Funding Keeps Momentum Amid IPO Wave; Plus Q2’s Top 10 Deals 07/10/18 National
Down the Stretch: Akcea, Alnylam Face Reality Checks as FDA Dates Loom 07/06/18 Boston
Bio Roundup: Dunsire’s Danish, Price Hikes, Rare-Disease Race & More 07/06/18 National
Boston Scientific Continues M&A Streak with $202M Deal for Cryterion 07/05/18 Boston
In Celebration of Bruce Bigelow: Our Memories, His Playlist 07/02/18 San Diego
Virtual Physical Therapy Firms Reflexion and MindMaze Probe Markets 07/02/18 San Francisco
Page 1 of 68 next page »